Malignant hyperthermia: a pharmacogenetic disorder.
Stratman
Rachel C
RC
Department of Pharmacy, Barnes-Jewish Hospital, St. Louis, MO 63110, USA. rcs1713@bjc.org
Flynn
Jeremy D
JD
Hatton
Kevin W
KW
D003620:Dantrolene / Q000627:therapeutic use; D020022:Genetic Predisposition to Disease; D006801:Humans; D008305:Malignant Hyperthermia / Q000235:genetics* / Q000503:physiopathology* / Q000628:therapy; D009125:Muscle Relaxants, Central / Q000627:therapeutic use; D009154:Mutation; D019837:Ryanodine Receptor Calcium Release Channel / Q000235:genetics*; D013577:Syndrome
D009125:Muscle Relaxants, Central; D019837:Ryanodine Receptor Calcium Release Channel; D003620:Dantrolene